Skip to content
Portage BioTech, LLC.
about us
overview
leadership
our pipeline
PORT-2 & PORT-3 – iNKT agonists
PORT-1 – Intratumoral Amphiphilic Formulations
PORT-4 – Nanolipogel Formulations
PORT-5 – STING Agonist with VLP Delivery
news
investors
overview
stock information
news releases
investor calendar
presentations & publications
sec filings
financial & regulatory reports
corporate governance
investor faqs
join our team
contact
about us
overview
leadership
our pipeline
PORT-2 & PORT-3 – iNKT agonists
PORT-1 – Intratumoral Amphiphilic Formulations
PORT-4 – Nanolipogel Formulations
PORT-5 – STING Agonist with VLP Delivery
news
investors
overview
stock information
news releases
investor calendar
presentations & publications
sec filings
financial & regulatory reports
corporate governance
investor faqs
join our team
contact
Daily Archives:
January 10, 2022
BioSpace: Biopharma Executive Perspectives on 2022
Media Coverage
By
Gwen Schanker
January 10, 2022
...
Go to Top